Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
The American Journal of Surgical Pathology|October 2, 2015
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive DiseaseDaniel Martinez, Alba Navarro, Alejandra Martinez-Trillos, et al.British Journal of Haematology|August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 casesCarlos Montalbán, Víctor Abraira, Luca Arcaini, et al.Ejhaem|October 17, 2024
The genomic landscape of transformed splenic diffuse red pulp small B-cell lymphomaMarta Grau, Melina Pol, Anna Montaner, et al.European Journal of Haematology|June 22, 2010
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 casesPetr Lemez, Andishe Attarbaschi, Marie C Béné, et al.British Journal of Haematology|September 14, 2021
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformationGabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trialAndrew R Pettitt, Richard Jackson, Stacey Carruthers, et al.Hematological Oncology|March 30, 2023
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviorsPablo Mozas, Cristina López, Marta Grau, et al.Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2015
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 ReceptorsVasilis Bikos, Maria Karypidou, Evangelia Stalika, et al.Pageof 11